Searchable abstracts of presentations at key conferences in endocrinology

ea0028p66 | Clinical practice/governance and case reports | SFEBES2012

Correcting hyponatraemia on the AMU: learn to walk before you can run?

Webb David , Witherall Ruth , Ellis Holly , Griffiths Adam , Levy Miles

Introduction: Significant hyponatraemia (serum sodium <128 mmol/l) is a potentially modifiable cause of prolonged hospital length of stay (LOS). By correcting euvolaemic hyponatraemia more rapidly than imposed fluid restriction, vasopressin receptor-2 antagonists may be useful adjuncts to existing treatments.Aim: To explore the potential clinical utility of vasopressin antagonists by describing the frequency and nature of hyponatraemia typically enco...